230 related articles for article (PubMed ID: 17352953)
1. Seizure associated with total parenteral nutrition-related hypermanganesemia.
Hsieh CT; Liang JS; Peng SS; Lee WT
Pediatr Neurol; 2007 Mar; 36(3):181-3. PubMed ID: 17352953
[TBL] [Abstract][Full Text] [Related]
2. [Spontaneous hyperintensity of the anterior pituitary gland in MRI T1-weighted images related to manganese deposits in a patient undergoing prolonged parenteral nutrition].
Diniz RL; Reimund JM; Duclos B; Reis M; Baumann R; Dietemann JL
J Radiol; 1998 Apr; 79(4):345-7. PubMed ID: 9757262
[TBL] [Abstract][Full Text] [Related]
3. [Brain MRI associated with chronic hepatic failure and hypermanganism].
Aissi M; Nifle C; Roussin Bretagne S; Hubert C; Cordoliani YS; Pico F
Rev Neurol (Paris); 2010 Feb; 166(2):248-52. PubMed ID: 19497604
[TBL] [Abstract][Full Text] [Related]
4. Hypermanganesemia in patients receiving total parenteral nutrition.
Fitzgerald K; Mikalunas V; Rubin H; McCarthey R; Vanagunas A; Craig RM
JPEN J Parenter Enteral Nutr; 1999; 23(6):333-6. PubMed ID: 10574481
[TBL] [Abstract][Full Text] [Related]
5. Is manganese an essential supplement for parenteral nutrition?
Hardy IJ; Gillanders L; Hardy G
Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):289-96. PubMed ID: 18403926
[TBL] [Abstract][Full Text] [Related]
6. Extrapyramidal symptoms in a BMT recipient with hyperintense basal ganglia and elevated manganese.
Fredstrom S; Rogosheske J; Gupta P; Burns LJ
Bone Marrow Transplant; 1995 Jun; 15(6):989-92. PubMed ID: 7581103
[TBL] [Abstract][Full Text] [Related]
7. Effects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition.
Abdalian R; Saqui O; Fernandes G; Allard JP
JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):538-43. PubMed ID: 22829428
[TBL] [Abstract][Full Text] [Related]
8. Manganese in Whole Blood and Hair in Patients with Long-Term Home Parenteral Nutrition.
Dastych M; Dastych M; Senkyrík M
Clin Lab; 2016; 62(1-2):173-7. PubMed ID: 27012047
[TBL] [Abstract][Full Text] [Related]
9. Manganese intoxication during intermittent parenteral nutrition: report of two cases.
Masumoto K; Suita S; Taguchi T; Yamanouchi T; Nagano M; Ogita K; Nakamura M; Mihara F
JPEN J Parenter Enteral Nutr; 2001; 25(2):95-9. PubMed ID: 11284477
[TBL] [Abstract][Full Text] [Related]
10. Parkinsonism caused by chronic usage of intravenous potassium permanganate.
Meral H; Kutukcu Y; Atmaca B; Ozer F; Hamamcioglu K
Neurologist; 2007 Mar; 13(2):92-4. PubMed ID: 17351530
[TBL] [Abstract][Full Text] [Related]
11. [A patient with parkinsonism presenting hyperintensity in the globus pallidus on T1-weighted MR images: the correlation with manganese poisoning].
Katsuragi T; Takahashi T; Shibuya K; Nagatomo H; Iwabuchi K
Rinsho Shinkeigaku; 1996 Jun; 36(6):780-2. PubMed ID: 8937201
[TBL] [Abstract][Full Text] [Related]
12. Factors associated to hypermanganesemia in patients receiving home parenteral nutrition.
Reimund JM; Dietemann JL; Warter JM; Baumann R; Duclos B
Clin Nutr; 2000 Oct; 19(5):343-8. PubMed ID: 11031073
[TBL] [Abstract][Full Text] [Related]
13. Manganese deposition in the brain during long-term total parenteral nutrition.
Ono J; Harada K; Kodaka R; Sakurai K; Tajiri H; Takagi Y; Nagai T; Harada T; Nihei A; Okada A
JPEN J Parenter Enteral Nutr; 1995; 19(4):310-2. PubMed ID: 8523631
[TBL] [Abstract][Full Text] [Related]
14. Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity.
Klos KJ; Ahlskog JE; Josephs KA; Fealey RD; Cowl CT; Kumar N
Arch Neurol; 2005 Sep; 62(9):1385-90. PubMed ID: 16157745
[TBL] [Abstract][Full Text] [Related]
15. [An 8-year-old boy presenting with progressive extrapyramidal symptoms during total parenteral nutrition].
Kikuchi A
No To Hattatsu; 2009 Sep; 41(5):325-6. PubMed ID: 19764449
[No Abstract] [Full Text] [Related]
16. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
[TBL] [Abstract][Full Text] [Related]
17. Neuroimaging identifies increased manganese deposition in infants receiving parenteral nutrition.
Aschner JL; Anderson A; Slaughter JC; Aschner M; Steele S; Beller A; Mouvery A; Furlong HM; Maitre NL
Am J Clin Nutr; 2015 Dec; 102(6):1482-9. PubMed ID: 26561627
[TBL] [Abstract][Full Text] [Related]
18. Basal ganglial signal intensity alterations: reversal after discontinuation of parenteral manganese administration.
Mirowitz SA; Westrich TJ
Radiology; 1992 Nov; 185(2):535-6. PubMed ID: 1410368
[TBL] [Abstract][Full Text] [Related]
19. Assessment of latent manganese toxicity as a prognostic factor following surgery for biliary atresia.
Agarwal GS; Sharma R; Bhatnagar V
Eur J Pediatr Surg; 2008 Feb; 18(1):22-5. PubMed ID: 18302065
[TBL] [Abstract][Full Text] [Related]
20. Temporal parenteral nutrition in children causing t1 shortening in the anterior pituitary gland and globus pallidus.
Suzuki H; Takanashi J; Saeki N; Kohno Y
Neuropediatrics; 2003 Aug; 34(4):200-4. PubMed ID: 12973661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
